Skip to main content

CLIENT SUCCESS

Streamlining Publications
Development with Real-
Time Co-Authoring

A leading drug company leveraged co-authoring technology to simplify and expedite the manuscript development process.

GOALS

A team within a multibillion-dollar pharmaceutical company wanted to rethink the publication development process. Primary goals included:

  1. Finalize a manuscript as quickly as possible
  2. Improve the overall experience for authors and keep them engaged throughout
  3. Establish a repeatable process for future publications

SOLUTION

The pharmaceutical company used the Within3 insights management platform’s document co-authoring capability, which provides a single, central document where any number of authors can add contributions and see each other’s input in real-time, from any device, whenever it is convenient for them. Authors stayed engaged through built-in tools like a daily digest email alerting them to new comments and responses, and the ability for the medical writer to remind authors who needed to contribute or respond to a query.

The company kicked off the manuscript development process with a ten-day session to provide five authors the opportunity to create the first-draft outline. The next phase was a three-week draft review session, during which authors had the opportunity to contribute to the first draft of the manuscript. The authors were able to view related resources, read the article, make comments or queries, and respond to questions. The third and final session focused on the second draft of the article and was available to the authors during a two-week review session for further refinement and final adjudication of any issues.

RESULTS

With the flexibility of the over-time discussion platform and document co-authoring capability, the pharmaceutical company completely transformed its manuscript development process. The company realized several valuable benefits by using the document co-authoring platform:

  1. Reduced the timeframe needed to create publication by several months
  2. Created higher quality publication due to enhanced collaboration
  3. Improved author satisfaction
insights management R&D gains

Within3 in The Medicine Maker: insights management for R&D gains

October 6, 2022 | News | No Comments
Adopting solutions that provide human-centric knowledge will be the key to increasing the value generated from the pharmaceutical industry’s tech investment.
AI in life science

Within3 in Pharmafield: understand the power of AI in life science

September 26, 2022 | News | No Comments
Within3 CTO, AI & Analytics Jason Smith talks to Pharmafield about AI technology in pharma, wearables, the impact of social media, and more.

More insights, direct to your inbox.

Get our newsletter.